An increase suggests successful leverage of external partnerships to drive sales, while a decrease may indicate expiring agreements or shifting commercial strategies.
Revenue generated through collaborative arrangements, co-promotion agreements, or profit-sharing partnerships with other...
Commonly reported by large pharma firms as 'collaboration revenue' or 'co-promotion income' in peer financial statements.
pfe_alliance_revenues